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ABSTRACT
Macrophage migration inhibitory factory (MIF) regulates macrophage accumulation at sites of injury and
can promote the inflammatory response. We studied MIF expression in the intragastric feeding rat model for
alcoholic liver injury. Male and age-matched female rats were fed ethanol or dextrose with fish oil. Two groups
of male rats were fed medium-chain triglycerides with ethanol or dextrose. Analysis of liver histopathology,
lipid peroxidation, endotoxin, mRNA, and immunohistochemistry for MIF, tumor necrosis factor-a (TNF-a)
and interferon-g (IFN-g) were carried out. Male and female rats fed fish oil and ethanol showed necroin-
flammatory liver injury and had the highest expression of MIF, TNF-a, and IFN-g in the liver. Decreased
levels of MIF protein were seen in rats with higher endotoxin levels, suggesting that preformed MIF is re-
leased into the circulation. MIF is an important mediator of the inflammatory response in alcoholic liver dis-
ease and a potential therapeutic target.
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INTRODUCTION
ALCOHOLIC LIVER INJURY is a complex process involving sev-eral injury mechanisms and multiple cellular targets.(1)
Several studies indicate that endotoxin and oxidative stress are
important pathogenic mechanisms in alcohol-induced liver in-
jury.(2–5) It is well known that endotoxin is hepatotoxic and that
concentrations of endotoxin are increased in alcoholic liver dis-
ease in experimental animals and humans.(2,3,6) One pathway
by which endotoxemia and oxidative stress can cause liver in-
jury is through activation of nuclear factor k B (NF-kB), which
upregulates the production of proinflammatory cytokines, such
as tumor necrosis factor-a (TNF-a) and interferon-g (IFN-
g).(7–9)
A key molecule that upregulates TNF-a and IFN-g and pro-
motes the inflammatory response is macrophage migration in-
hibitory factor (MIF).(10,11) MIF was originally described as a
lymphokine derived from activated T cells that inhibited the
migration of macrophages.(12) Subsequently, it was shown that
MIF is expressed in a variety of cells and tissues, including the
liver.(10) Based on the information available about factors that
stimulate expression of MIF, we hypothesized that MIF would
be induced in experimental alcoholic liver disease (ALD).
To evaluate the relationship between pathologic liver injury
and expression of MIF, we used the rat intragastric feeding
model for ALD.(13,14) We and others have shown an inverse re-
lationship between the saturation of lipids in the diet and the
severity of alcohol-induced liver injury.(15,16) Rats fed ethanol
and a diet enriched in saturated fatty acids are protected from
liver injury,(16) whereas diets enriched in polyunsaturated fatty
acids promote alcoholic liver injury.(15) We and others have
also shown that female rats are more susceptible to alcoholic
liver injury than male rats and show more severe necrosis and
inflammation.(17) Thus, the intragastric feeding model using
male and female rats is useful to elucidate the relationship be-
tween pathologic changes in liver and proinflammatory medi-
ators, such as MIF.
Our results show that necrosis and inflammation in ALD are
associated with increased expression of MIF. The Kupffer cell
and other mononuclear cells are the most likely source of MIF,
although endothelial cells and hepatocytes also make a contri-
bution. The upregulation of IFN-g and TNF-a in association
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with MIF also contributes to the inflammatory changes in al-
coholic liver injury.
MATERIALS AND METHODS
Animals
Male Wistar rats weighing between 275 and 300 g were
fed a liquid diet by continuous infusion through permanently
implanted gastric tubes as described previously.(13,14) The
rats were given their total nutrient intake by intragastric in-
fusion. The percentage of calories derived from fat was 35%
of total calories. Vitamins and minerals were given as de-
scribed previously.(14) The amount of ethanol was modified
to maintain high levels of blood ethanol (150–300 mg/dl)
throughout the day. The amount of ethanol was initially 10
g/kg/day and was increased to 16g/kg/day as tolerance de-
veloped. Each ethanol-fed rat had at least two measurements
of blood alcohol.
In the first set of experiments, six groups of rats (5 rats per
group) fed different dietary fats with ethanol or dextrose were
studied. These groups were male rats fed medium-chain triglyc-
erides plus dextrose (MCTD) or ethanol (MCTE) and fish oil
plus dextrose (FD) or ethanol (FE). In addition, age-matched
female rats were fed fish oil and dextrose (FFD) or ethanol
(FFE). All control animals were pair-fed the same diet as eth-
anol-fed rats except that ethanol was isocalorically replaced by
dextrose. All diets were prepared fresh daily. All animals were
killed after 1 month of treatment with the experimental diets.
When the animals were killed, a sample of liver was obtained
for histopathologic analysis, and the rest of the liver was rapidly
excised, washed with ice-cold 1.15% (w/v) KCl, and cut into
small pieces. The liver specimens were transferred to plastic
vials and placed in liquid nitrogen, and the vials were stored at
280°C. All animals received humane care in compliance with
the National Institutes of Health criteria for care of laboratory
animals.
In the second set of experiments, which were designed to
evaluate the cellular source of MIF, IFN-g, and TNF-a mRNA,
six groups of animals were evaluated (MCTD, MCTE, FD, FE,
FFD, and FFE). All animals were killed after treatment with
the experimental diets for 1 month.
Isolation of hepatocytes, Kupffer cells, 
and endothelial cells
Cells were isolated from anesthetized rats using procedures
described previously(18) and isolation buffers described by
Seglen.(19) Hepatocytes, Kupffer cells, and endothelial cells
were isolated as previously described.(20) Briefly, after intra-
venous administration of sodium heparin (100 U), the livers
were exsanguinated in situ by portal vein perfusion with Ca21-
free buffer. Livers were excised, minced, and subsequently in-
cubated in 0.05% collagenase in buffer. The different cell types
were identified by morphology and immunohistochemical
markers that included peroxidase, acid phosphatase, a1-anti-
chymotrypsin, ED1, and cytokeratins.(21) Endothelial cells were
the nonadherent cells from the Kupffer cell preparation and
were placed onto type 1 collagen-coated dishes. The cells were
stored at 270°C.
Histopathologic analysis
A small sample of the liver was obtained and formalin-fixed
when the rats were killed. H & E stain was used for light mi-
croscopy. The severity of liver pathology was assessed as fol-
lows: steatosis (the percentage of liver cells containing fat) was
scored 11 with ,25% of the cells containing fat, 21 with
26%–50% of the cells containing fat, 31 with 51%–75% of the
cells containing fat, and 41 with .75% of the cells contain-
ing fat. Necrosis was quantified as the number of necrotic foci
per square millimeter, and inflammation was scored as the num-
ber of inflammatory cells per square millimeter. At least three
different sections were examined per sample of liver. The
pathology was assessed blindly without knowledge of the ex-
perimental groups.
Measurement of blood alcohol
Blood was collected from the tail vein, and ethanol concen-
tration was measured using an alcohol dehydrogenase kit from
Sigma Chemical Co. (St. Louis, MO).
Measurement of conjugated dienes
Conjugated dienes in the total lipid extracted from liver ho-
mogenates were determined as described previously.(20)
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TABLE 1. PATHOLOGIC CHANGES IN EXPERIMENTAL GROUPS
Fatty liver Necrosis Inflammation
Treatment group (0–4) (foci/mm2) (cells/mm2)
Medium-chain triglycerides 1 dextrose (MCTD) 0.0 0.0 0.0
Medium-chain triglycerides 1 ethanol (MCTE) 0.0 0.07 6 0.0400 0.0
Fish oil 1 dextrose (FD) 0.0 0.08 6 0.0400 0.6 6 0.02000
Fish oil 1 ethanol (FE) 4.0 6 0.0* 1.1 6 0.4*0 21.2 6 7.3*0000
Female fish oil 1 dextrose (FFD) 2.0 6 0.4*,** 0.4 6 0.2*,** 8.2 6 2.3*,**0
Female fish oil 1 ethanol (FFE) 4.0 6 0.0*00. 1.4 6 0.4*0 54.5 6 11.8*,***
*p , 0.01 vs. MCTD, MCTE, FD.
**p , 0.05 vs. FE, FFE.
***p , 0.05 vs. FE.
Measurement of plasma endotoxin
Endotoxin in plasma was measured as described previ-
ously(3) using the appropriate precautionary measures.(22)
Analysis of mRNA for MIF, TNF-a, IFN-g, and 
b-actin by reverse transcriptase-polymerase 
chain reaction (RT-PCR)
To examine the expression of MIF, TNF-a, IFN-g, and b-
actin in liver tissue and cells, total RNA was isolated accord-
ing to the guanidinium isothiocyanate method.(23) The integrity
of RNA was assessed by agarose gel electrophoresis and ethid-
ium bromide staining. RT-PCR was performed essentially as
previously described.(20,24) The sequences of primer pairs, 59
and 39, and predicted sizes of the amplified PCR fragments for
MIF, TNF-a, IFN-g, and b-actin have been reported previ-
ously.(20,25,26 PCR products and molecular weight markers were
subjected to electrophoresis on 1% agarose gels and visualized
by means of ethidium bromide staining. The gels were analyzed
by laser scanning densitometry using a Molecular Dynamics
Densitometer and Image Quant software (Molecular Dynamics,
Sunnyvale, CA). Each experiment included a negative control
(sample RNA that had not been subjected to RT). Varying the
number of PCR cycles did not change the relative differences
between the samples, indicating that the PCR conditions were
not within the plateau phase of amplification. All amplification
reactions of one experiment were performed in parallel in the
same heating block to ensure compatible conditions.
In situ hybridization and immunohistochemical
analysis of MIF
In situ hybridization was performed on paraffin sections of
formalin-fixed tissue with MIF antisense or sense cRNA probes
as previously described.(27,28) MIF protein expression was de-
termined by immunostaining with the antimouse MIF mono-
clonal antibody (mAb). The specificity of the antisense probe
and anti-MIF antibody was confirmed as described previ-
ously.(27,28) In addition, some sections were also stained with
the ED1 mAb using the peroxidase-antiperoxidase (PAP)
method and counterstained with periodic acid-Schiff for im-
munohistochemical analysis of MIF. The sections were scored
as previously described (10): 0, negative; 1, 20 positively stain-
ing cells per high-power field (HPF); 21, 20–40 positive cells
per HPF; and 31, .40 cells per HPF.
Statistical analysis
All data are expressed as means 6 SD unless otherwise in-
dicated. Statistical significance was evaluated using the un-
paired Student’s t-test for comparison between two means. Dif-
ferences between more than 2 groups were analyzed using
analysis of variance (ANOVA). Statistical significance was set
at p , 0.05.
RESULTS
Some of the results, such as histopathologic findings, have
been described previously for some of the animals included
in other studies.(20,24) There was no difference in weight gain
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FIG. 1. Quantitation of MIF, TNF-a, and IFN-g expression
in the various experimental groups. MIF expression was de-
tectable in the MCTD, MCTE, and FD groups. MIF mRNA was
significantly increased in FE rats compared with MCTD,
MCTE, and FD groups (p , 0.01). Female rats fed fish oil and
dextrose had significantly higher levels of MIF mRNA com-
pared with MCTD and MCTE (p , 0.02) and FD groups (p ,
0.05). Female fish oil plus ethanol-fed rats had higher MIF
mRNA levels compared with MCTD, MCTE, FE, and FFD
groups (p , 0.01). TNF-a mRNA was not detected in MCTD
and MCTE groups and was increased in FE, FD, and FFD
groups in comparison to other groups (p , 0.01). IFN-g was
not detected in MCTD, MCTE, and FD groups. Levels of IFN-
g were highest in FE and FFE groups. All mRNA levels were
quantified using b-actin as standard. *p , 0.01 vs. MCTD,
MCTE, FD groups; **p , 0.02 vs. MCTD and MCTE groups;
†p , 0.05 vs. FD; ‡p , 0.05 vs. FFD and p , 0.01 vs. MCTD,
MCTE, FD. MCT, medium-chain triglycerides; F, fish oil; FF,
female fish oil; D, dextrose; E, ethanol.
among the different experimental groups (data not shown). No
significant difference in blood alcohol levels was found among
the ethanol-fed groups. The blood alcohol levels in the etha-
nol-fed groups were as follows: MCTE 232 6 38 mg/dl, FE
229 6 31 mg/dl, and FFE 242 6 24 mg/dl. The amount of al-
cohol administered (g/kg) was not different in the different
groups.
Histopathology
The most severe pathology was seen in the male and female
ethanol-fed rats (Table 1). In particular, the degree of necrosis
and inflammation was much more severe in female rats. The
male dextrose-fed rats showed no pathologic signs. In contrast,
the female dextrose-fed rats had fatty liver, necrosis, and in-
flammation.
Enhanced expression of MIF and TNF-a and
correlates with inflammatory changes, endotoxemia,
and lipid peroxidation
We examined liver tissue for MIF by RT-PCR. MIF mRNA
normalized using b-actin was detected in all experimental
groups; However, the groups showing necrosis and inflamma-
tion and having increased levels of lipid peroxidation and en-
dotoxin had the highest levels of MIF mRNA (Fig. 1 and Table
2). Because MIF upregulates TNF-a and IFN-g, we also eval-
uated mRNA levels of these two cytokines in liver. Our results
show that upregulation of TNF-a and IFN-g mRNA is similar
to that seen with MIF in the different experimental groups 
(Fig. 1).
Cellular origin of MIF mRNA
We next attempted to determine the cell type in liver re-
sponsible for increased MIF mRNA. Hepatocytes, Kupffer
cells, and endothelial cells were isolated from the rats fed the
different experimental diets. MIF mRNA was detected in all
three cell types in all the groups. The highest levels of MIF
mRNA were seen in all cell types in the fish oil-ethanol-fed
male and female rats (Table 3). Because the isolation procedure
yields Kupffer and endothelial cells with 85%–90% purity, we
cannot exclude the possibility that detectable levels of MIF
mRNA in endothelial cells and hepatocytes in the rats exhibit-
ing liver injury reflected contamination by Kupffer cells.
Increased MIF mRNA is associated with increased
mRNA levels of TNF-a and IFN-g
Based on experimental evidence that MIF production can
upregulate TNF-a and IFN-g synthesis and our observation
that TNF-a and IFN-g are upregulated in conjunction with
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TABLE 2. LEVELS OF PLASMA ENDOTOXIN AND CONJUGATED DIENES
(A232) IN LIVER IN EXPERIMENTAL GROUPS
Endotoxin
Treatment group (pg/ml) A232
Medium-chain triglycerides 1 dextrose (MCTD) 5 6 3 0.06 6 0.02
Medium-chain triglycerides 1 ethanol (MCTE) 12 6 5 0.12 6 0.05
Fish oil 1 dextrose (FD) 7 6 2 0.39 6 1.16***
Fish oil 1 ethanol (FE) 62 6 11* 0.67 6 0.18*
Female fish oil 1 dextrose (FFD) 22 6 4*,** 0.44 6 0.19***
Female fish oil 1 ethanol (FFE) 84 6 14*,**** 0.86 6 0.22*,****
*p , 0.01 vs. MCTD, MCTE, FD.
**p , 0.01 vs. FD, FFE.
***p , 0.01 vs. MCTD, MCTE.
****p , 0.01 vs. FFD.
TABLE 3. MIF MRNA LEVELS IN VARIOUS CELL TYPES IN EXPERIMENTAL GROUPS
Cell type
Treatment group Kupffer Endothelial Hepatocyte
Medium-chain triglycerides 1 dextrose (MCTD) 1.0 1.0 1.0
Medium-chain triglycerides 1 ethanol (MCTE) 0.9 6 0.3 0.8 6 0.4 1.3 6 0.3
Fish oil 1 dextrose (FD) 1.4 6 0.5 1.0 6 0.4 1.8 6 0.8
Fish oil 1 ethanol (FE) 7.0 6 2.6* 6.4 6 1.9* 3.2 6 1.1***
Female fish oil 1 dextrose (FFD) 3.2 6 1.2** 3.0 6 0.9** 3.6 6 0.7***
Female fish oil 1 ethanol (FFE) 8.6 6 3.0* 7.6 6 2.1* 4.2 6 2.0***
*p , 0.01 vs. MCTD, MCTE, FD.
**p , 0.05 vs. FD, FFE.
***p , 0.05 vs. MCTD, MCTE.
MIF in liver, we also determined TNF-a and IFN-g mRNA
in the different cell types. Our results show that TNF-a and
IFN-g are also increased in the same groups that show in-
creased MIF (FE, FFD, FFE) (Table 4). In contrast to the cel-
lular expression of MIF that occurred in all three cell types,
the increase in TNF-a and IFN-g was restricted mainly to
Kupffer cells (Table 4).
In situ hybridization and immunohistochemical
analysis of MIF
In situ hybridization confirmed the low level of MIF ex-
pression in the livers of rats without evidence of liver injury
(Fig. 2). In animals showing the presence of necrosis and in-
flammation, there was a marked increase in MIF mRNA ex-
pression (Fig. 2). The increased expression of MIF in hepato-
cytes confirmed the results of RT-PCR analysis. Combined in
situ hybridization and immunohistochemistry showed that ED1-
positive Kupffer cells were the major source of MIF (data not
shown).
In the animals showing necroinflammatory changes, the level
of MIF protein, detected immunohistochemically, was higher
from that seen in dextrose-fed animals. In fact, in some of the
animals exhibiting liver injury, the immunostaining intensity
was low despite the presence of necroinflammatory changes.
Because of the known association between high levels of en-
dotoxin and loss of MIF protein expression, we divided the rats
in the FE groups into those with levels of endotoxin ,50 pg/ml
and .50 pg/ml at the time of killing. Of the 10 animals fed FE,
6 had a level of .50 pg/ml. The meaning staining intensity in
the rats with endotoxin levels of .50 pg/ml was 1.3 (1.3 6 0.5)
compared with 2.8 (2.8 6 0.4) in rats with endotoxin levels ,50
pg/ml (p , 0.05).
DISCUSSION
Over the past few years, MIF has emerged as a pivotal cy-
tokine that plays an important role in the control of inflamma-
tory processes.(10,27–30) MIF, originally described as a T cell cy-
tokine, was subsequently found to be produced by macrophages
and monocytes in response to endotoxin.(10) Once released, MIF
induces the expression of other proinflammatory mediators,
thereby promoting and amplifying the inflammatory re-
sponse.(10) The results of the present study indicate that upreg-
ulation of MIF occurs in association with inflammatory changes
in the liver and coincides with increased levels of endotoxin
and lipid peroxidation and upregulation of TNF-a and IFN-g.
Our hypothesis is that upregulation of MIF, TNF-a, and IFN-
g, which occurs in association with endotoxemia and lipid per-
oxidation, promotes necroinflammatory changes in alcoholic
liver injury. TNF-a levels are increased in both experimental
and human ALD,(25,31) and TNF-a contributes to inflammatory
changes in the liver.(32) An important function of IFN-g is mod-
ulation of cytokine production.(24) IFN-g induces TNF-a syn-
thesis and also production of other proinflammatory cytokines,
such as interleukin-12.(33) The mechanism regulating TNF-a,
and IFN-g production in necroinflammatory liver injury, how-
ever, remains unclear. In vitro, MIF directly induces TNF-a
and IFN-g production,(34) demonstrating that MIF is a key mol-
ecule responsible for TNF-a and IFN-g production by macro-
phages. Unlike TNF-a and IFN-g, which are inducible, MIF is
preformed. It is very possible that MIF is rapidly released from
the intracellular store of both Kupffer cells and hepatocytes af-
ter alcoholic stress. Once released, MIF acts as the first proin-
flammatory cytokine to induce TNF-a and IFN-g expression.
Therefore, MIF may play a key pathogenic role in liver in-
flammation.
To examine MIF production by individual cell types, hepa-
tocytes, endothelial cells, and Kupffer cells were isolated from
rats in the different experimental groups. Increased expression
of MIF was seen in all cell types in the livers of alcohol-fed
rats showing evidence of pathologic liver injury (MFE and
FFE). By in situ hybridization and immunostaining, Kupffer
cells were shown to be the major MIF-producing cells, consis-
tent with the functional role of this cell in the liver inflamma-
tory response. MIF secreted by nonmacrophage-type cells, such
as hepatocytes, can halt macrophage migration and promote
macrophage accumulation in the vicinity of MIF-producing
cells. It is noteworthy that increased levels of MIF production
by hepatocytes correlated with inflammatory changes. The in-
creased levels of MIF, TNF-a, and IFN-g in the Kupffer cell
are consistent with previous observations that describe a major
role for the Kupffer cell in alcoholic liver injury.(5) The Kupf-
fer cell is the predominant immune and inflammatory effector
cell in the liver and, in response to such stimuli as endotoxin
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TABLE 4. EXPRESSION OF TNF-a AND IFN-g MRNA IN KUPFFER AND ENDOTHELIA L CELLS IN EXPERIMENTAL GROUPSa
Kupffer cells Endothelial cells
Treatment group TNF-a IFN-g TNF-a IFN-g
Medium-chain triglycerides 1 dextrose (MCTD) 0 0 0 0
Medium-chain triglycerides 1 ethanol (MCTE) 0 0 0 0
Fish oil 1 dextrose (FD) 1.0 0 0 0
Fish oil 1 ethanol (FE) 4.0 6 1.9*00. 3.6 6 1.4*00. 1b 1
Female fish oil 1 dextrose (FFD) 1.9 6 0.7*00. 2.2* 6 0.800.00 1b 1
Female fish oil 1 ethanol (FFE) 7.0 6 1.9*,** 8.1 6 2.2*,** 1b 1
aNo mRNA for TNF-a or IFN-g was detected in the hepatocytes in any of the experimental groups.
b1, faint band for mRNA seen.
*p , 0.01 vs. MCTD, MCTE, FD.
**p , 0.01 vs. FFD.
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FIG. 2. MIF expression in the liver of rats fed ethanol and different dietary fats. In rats showing no evidence of liver injury,
that is, rats fed MCTD, MCTE, and FD, a low level of MIF mRNA expression was seen in liver. (A) A representative section
of liver from a rat fed MCTD is shown. (B) Rats fed FD showed increased MIF mRNA expression, with hepatocytes around the
central vein showing the highest expression. Immunohistochemical analysis of rat liver shows low staining for MIF protein in
rats fed MCTD, MCTE, and FD. (C) A representative section of liver from a rat fed MCTD is shown. (D) In rats fed FE, in-
creased staining intensity was seen in the liver, especially in the centrilobular area. (E) In some of the rats fed FE, however, the
staining intensity was decreased in hepatocytes but remained high in the Kupffer cells. (F) In a female rat fed FE, the staining
intensity for MIF in hepatocytes was lower than that seen in (D and E) the male FE rat. The Kupffer cells, however, showed in-
creased MIF staining.
and lipid peroxidation, generates proinflammatory stimuli, such
as cytokines and eicosanoids. MIF may also promote hepatic
stellate cell proliferation by increasing production of such
growth factors as platelet-derived growth factor.(35) The direct
link between MIF and secretion of growth factors by hepatic
stellate cells remains to be established.
The increase in MIF mRNA without an accompanying in-
crease in MIF protein suggests that MIF exists as a preformed
protein in the liver and is rapidly released on stimulation.(10,27)
Resident macrophages in the liver respond to endotoxin by in-
creasing the mRNA levels, although not that of MIF protein.
In fact, MIF immunostaining in most tissues in endotoxin-
treated rats is weak, suggesting loss of MIF protein into the cir-
culation.(10) Our results show depleted levels of immunoreac-
tive MIF protein and increased MIF mRNA in rats with the
higher levels of endotoxin, suggesting release of preformed MIF
into the circulation. These results are consistent with observa-
tions showing that an abrupt loss of MIF protein in liver occurs
6 h after endotoxin administration, and by 24 h, immunoreac-
tivity to MIF is restored.(10) As a possible explanation for the
variability of endotoxin-mediated loss of MIF immunoreactiv-
ity in our study, it is well known that in rats fed ethanol intra-
gastrically, a cycling of endotoxin levels is observed.(9) Thus,
the variability of endotoxin levels seen in the rats at death prob-
ably reflects the cycling of endotoxin in blood, and loss of MIF
immunostaining in rats with the higher endotoxin levels is con-
sistent with endotoxin-mediated release of preformed MIF.
Recent observations made in our laboratory also provide ad-
ditional insights into the mechanism that may account for MIF-
mediated effects in alcoholic liver injury. MIF stimulates phos-
pholipase A2 activity and arachidonic acid release, suggesting
the possibility that the arachidonic acid-eicosanoid pathway is
an important component of MIF-mediated effects.(36) We have
previously shown increased phospholipase and cyclooxyge-
nase-2 activities in ethanol-fed rats exhibiting pathologic liver
injury.(20) In conjunction with previous studies in the intragas-
tric feeding rat model for alcoholic liver injury, which show an
increase in the levels of proinflammatory cytokines and
eicosanoids, the results of the present study assign a critical role
for MIF in the pathogenesis of alcoholic liver injury.
In conclusion, our results suggest that MIF is an important
mediator of the inflammatory response in ALD. Given the cen-
tral role of MIF in the immune response, MIF is an attractive
therapeutic target in the treatment of inflammatory liver injury.
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